These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8972281)

  • 1. HIV-1 and Kaposi's sarcoma.
    Ensoli B; Cafaro A
    Eur J Cancer Prev; 1996 Oct; 5(5):410-2. PubMed ID: 8972281
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1, HHV-8, and Kaposi's sarcoma.
    Gallo RC
    J Hum Virol; 1998; 1(3):185-6. PubMed ID: 10195240
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency virus type 1 infection and Kaposi's sarcoma.
    Demirhan I; Chandra A; Mueller F; Mueller H; Biberfeld P; Hasselmayer O; Chandra P
    J Hum Virol; 2000; 3(3):137-43. PubMed ID: 10881993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.
    Ensoli B; Gendelman R; Markham P; Fiorelli V; Colombini S; Raffeld M; Cafaro A; Chang HK; Brady JN; Gallo RC
    Nature; 1994 Oct; 371(6499):674-80. PubMed ID: 7935812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-related Kaposi's sarcoma: principal pathogenic mechanisms.
    Silvestris N
    J Exp Clin Cancer Res; 1999 Sep; 18(3):311-5. PubMed ID: 10606175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
    Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
    J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
    Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
    Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons.
    Renwick N; Weverling GJ; Schulz T; Goudsmit J
    J Infect Dis; 2001 May; 183(9):1427. PubMed ID: 11294681
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.
    Wu Z; Cavallaro U; Marchisio PC; Soria MR; Maier JA
    Am J Pathol; 1998 Jun; 152(6):1599-605. PubMed ID: 9626063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.
    Vogel J; Hinrichs SH; Reynolds RK; Luciw PA; Jay G
    Nature; 1988 Oct; 335(6191):606-11. PubMed ID: 2845275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis.
    Ensoli B; Salahuddin SZ; Gallo RC
    Cancer Cells; 1989 Nov; 1(3):93-6. PubMed ID: 2561910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.
    Yen-Moore A; Hudnall SD; Rady PL; Wagner RF; Moore TO; Memar O; Hughes TK; Tyring SK
    Virology; 2000 Feb; 267(2):247-51. PubMed ID: 10662620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide-ranging progress on KS therapies.
    Horn T; Gilden D
    GMHC Treat Issues; 1998 Feb; 12(2):8-16. PubMed ID: 11365219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma and AIDS.
    Reiss P; Lange JM; Kuiken CL; Goudsmit J
    Nature; 1990 Aug; 346(6287):801-2. PubMed ID: 2202906
    [No Abstract]   [Full Text] [Related]  

  • 18. [The etiology of Kaposi's sarcoma].
    Soriano V; Hewlett J
    Med Clin (Barc); 1991 May; 96(17):662-7. PubMed ID: 2056802
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Buonaguro L; Buonaguro FM; Tornesello ML; Beth-Giraldo E; Del Gaudio E; Ensoli B; Giraldo G
    Antibiot Chemother (1971); 1994; 46():62-72. PubMed ID: 7826041
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-cancer agents. Kaposi's sarcoma--past and future.
    TreatmentUpdate; 2008; 20(5):3-5. PubMed ID: 19248278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.